The top documents tagged [target validation]

Genomics in biopharmaceutical industry
Education Genomics in biopharmaceutical industry

40 views

Validating Theraputic Target Through Human Genetics
Documents Validating Theraputic Target Through Human Genetics

220 views

Drug repositioning: out of the box opportunities despite data and chemistry challenges Christopher A. Lipinski clipinski@meliordiscovery.com 1Lipinski
Documents Drug repositioning: out of the box opportunities despite data and chemistry challenges Christopher A. Lipinski [email protected] 1Lipinski

214 views

The human approach to target validation and drug discovery Dr. Alastair J. Riddell Chief Executive Officer Pharmagene 3 rd October, Tokyo
Documents The human approach to target validation and drug discovery Dr. Alastair J. Riddell Chief Executive Officer Pharmagene 3 rd October, Tokyo

215 views

Global Pharmacometrics Influencing Early Portfolio Decision Making Using Pre-Clinical M&S: how early is too early and when is it too late? Peter A Milligan
Documents Global Pharmacometrics Influencing Early Portfolio Decision Making Using Pre-Clinical M&S: how early is too early and when is it too late? Peter A Milligan

214 views

Crowdsourcing pharmacogenomic data analysis: PGRN-Sage RA Responder Challenge PGRN Spring Meeting April 30, 2013 HARVARD MEDICAL SCHOOL
Documents Crowdsourcing pharmacogenomic data analysis: PGRN-Sage RA Responder Challenge PGRN Spring Meeting April 30, 2013 HARVARD MEDICAL SCHOOL

217 views

Improve your R&D Effectiveness and Manage Your Intellectual Property Assets with Luxid ® for Life Sciences
Documents Improve your R&D Effectiveness and Manage Your Intellectual Property Assets with Luxid ® for Life Sciences

213 views

Current Opportunities and Future Trends at NIAID Carole A. Heilman, Ph.D. Director, Division of Microbiology and Infectious Diseases NIAID, NIH, DHHS April
Documents Current Opportunities and Future Trends at NIAID Carole A. Heilman, Ph.D. Director, Division of Microbiology and Infectious Diseases NIAID, NIH, DHHS April

227 views

Drug repositioning: out of the box opportunities despite data and chemistry challenges Christopher A. Lipinski clipinski@meliordiscovery.com
Documents Drug repositioning: out of the box opportunities despite data and chemistry challenges Christopher A. Lipinski [email protected]

47 views

ANTISENSE AND RIBOZYME TECHNOLOGY
Documents ANTISENSE AND RIBOZYME TECHNOLOGY

1.113 views

Chemaxon's chemo-informatics toolkit integration into the Affectis Data Management System
Documents Chemaxon's chemo-informatics toolkit integration into the Affectis Data Management System

37 views

NC-IUPHAR Newsletter Summer 2014
Documents NC-IUPHAR Newsletter Summer 2014

219 views